Impact News +++ KRONOS Worldwide GAAP EPS of -$0.72, revenue of $418.3M beats by $45.04M (SeekingAlpha) +++ KRONOS WORLDWIDE Aktie -3,64%

ELI LILLY Aktie

>ELI LILLY Aktienkurs

867.4 EUR +1.7% (TradegateBSX)

Ask: 866.6 EUR / 11 Stück

Bid: 862 EUR / 11 Stück

Tagesumsatz: 3030 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

ELI LILLY Aktie über LYNX handeln

Intraday

1 Jahr

>ELI LILLY Performance

1 Woche: -0,6%

1 Monat: -1,2%

3 Monate: +2,6%

6 Monate: +35,3%

1 Jahr: +8,2%

laufendes Jahr: -5,5%

>ELI LILLY Aktie

Name:

ELI LILLY

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US5324571083 / 858560

Symbol/ Ticker:

LLY (Frankfurt) / LLY (NYSE)

Kürzel:

FRA:LLY, ETR:LLY, LLY:GR, NYSE:LLY

Index:

S&P500

Webseite:

https://www.lilly.com/

Profil:

Eli Lilly and Company is a leading research-based pharmaceutical company founded in 1876 and headquartered in Indianapolis, Indiana. It discovers, develops, manufactures, and markets a broad portfolio..
>Volltext..

Marktkapitalisierung:

798366.05 Mio. EUR

Unternehmenswert:

829499.68 Mio. EUR

Umsatz:

56100.29 Mio. EUR

EBITDA:

27277.4 Mio. EUR

Nettogewinn:

17763.61 Mio. EUR

Gewinn je Aktie:

19.47 EUR

Schulden:

37755.09 Mio. EUR

Liquide Mittel:

6165.27 Mio. EUR

Operativer Cashflow:

14471.14 Mio. EUR

Bargeldquote:

0.21

Umsatzwachstum:

27.54%

Gewinnwachstum:

71.77%

Dividende je Aktie:

5.32 EUR

Dividendenrendite:

0.63%

Dividendenschätzung:

0.7%

Div. Historie:

13.02.26 - 1.457352€
14.11.25 - 1.2880499€

>weitere anzeigen...

Insiderhandel:

Suchwörter:

ELI LILLY, LILLY DEUTSCHLAND

Letzte Datenerhebung:

09.03.26

>ELI LILLY Kennzahlen

Aktien/ Unternehmen:

Aktien: 943.36 Mio. St.

Frei handelbar: 90.04%

Leerverk. Aktien: 0.68%

Rückkaufquote: 0.44%

Mitarbeiter: 50000

Umsatz/Mitarb.: 1.12 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 25.58%

Bewertung:

KGV: 43.87

KGV lG: 28.58

KUV: 14.09

KBV: 35.29

PEG-Ratio: 0.45

EV/EBITDA: 30.41

Rentabilität:

Bruttomarge: 83.04%

Gewinnmarge: 31.66%

Operative Marge: 45.56%

Managementeffizenz:

Gesamtkaprendite: 21.59%

Eigenkaprendite: 101.35%

>ELI LILLY Anleihen

>ELI LILLY Peer Group

Gesundheit, Diabetes- & Adipositas- Behandlung, Onkologie/ Krebs- Behandlung

>ELI LILLY Chart & Kurs - NYSE

>ELI LILLY News

10.03.26 - 00:00	Eli Lilly (LLY) Laps the Stock Market: Here′s Why (Zacks)
	In the closing of the recent trading day, Eli Lilly (LLY) stood at $1, denoting a +1.82% move from the preceding trading day....

09.03.26 - 19:36	Should You Buy Eli Lilly Stock Now or Wait for More of a Pullback? (Fool)
	Eli Lilly's stock is a bit expensive, even with a bit of a decline this year....

09.03.26 - 11:00	Zacks Market Edge Highlights: Caterpillar, Eli Lilly and Comfort Systems (Zacks)
	Caterpillar, Eli Lilly and Comfort Systems have been highlighted in this Market Edge article....

08.03.26 - 19:00	1 Dividend Stock to Buy Hand Over Fist and 1 to Avoid (Fool)
	Eli Lilly may be the GLP-1 leader, but its valuation is stretched....

07.03.26 - 17:48	Where Will Eli Lilly Stock Be in 10 Years? (Fool)
	Eli Lilly is at the head of the pharma pack today, but in a decade, the situation could look very different....

07.03.26 - 00:36	Down but Not Out: Is Novo Nordisk a Conditional Buy as Eli Lilly Leads the GLP‑1 Market? (Fool)
	Novo Nordisk looks cheap, but a rebound hinges on fixing execution and management credibility....

06.03.26 - 18:42	Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide (CNBC)
	Pharmaceutical stocks like Eli Lilly and Merck are good places to help investors ride out a recent rise in geopolitical turmoil, according to UBS....

06.03.26 - 18:30	WHO Foundation announces collaboration with Lilly to strengthen health systems for obesity care (PR Newswire)
	GENEVA, March 6, 2026 /PRNewswire/ -- The WHO Foundation announced a collaboration with Eli Lilly and Company that aims to support the WHO Foundation's global efforts to assess and strengthen health systems for obesity prevention and care. Obesity is one of the most pressing global health......

06.03.26 - 12:57	Roche′s Obesity Drug Shows Promise But Trails GLP-1 Giants Novo Nordisk, Eli Lilly (Benzinga)
	Roche and Zealand Pharma's obesity drug petrelintide showed up to 11% weight loss in a Phase 2 trial with strong safety results. Importance Rank: 1 read more...

06.03.26 - 12:33	Milliardenmarkt Adidpositas: Wer steht nach Eli Lilly und Novo Nordisk in den Startlöchern? (Der Aktionaer)
	Der Markt für Adipositas-Behandlungen boomt nach wie vor. Bis 2035 soll dieser ein Marktvolumen von mehr als 130 Milliarden Dollar erreichen. Das entspricht einem jährlichen Wachstum von rund zehn Prozent. Hauptakteure am Markt sind Eli Lilly und Novo Nordisk, aber auch andere bringen sich in Stellung, um in Zukunft ein Stück vom Kuchen abzubekommen....

06.03.26 - 12:06	15 Top Press Releases from February (PR Newswire)
	Including a caviar special from McDonald's, new arcade games and watch lineups, and acquisition news from Warner Bros. Discovery and Eli Lilly. Plus, a recap of February's trending topics: The Big Game, Winter Olympics, Valentine's Day and quarterly earnings reports. NEW YORK, March 6,......

06.03.26 - 08:46	Eli Lilly an wichtiger Unterstützung (LYNX)
	Die Eli Lilly-Aktie notiert nahe einer wichtigen Unterstützungszone, nachdem sich der Trend zuletzt abgeschwächt hat. Hält der Bereich und kommt es zu einer technischen Gegenbewegung?...

05.03.26 - 14:02	Lilly Launches Employer Connect Platform To Expand Access To Obesity Treatments (AFX)
	INDIANAPOLIS (dpa-AFX) - Eli Lilly and Company (LLY) on Thursday announced the launch of its Employer Connect platform, aimed at expanding access to obesity management treatments for employees.Lil......

05.03.26 - 12:12	Eli Lilly launches program to help boost employer coverage of obesity drugs in U.S. (CNBC)
	Employers can use Lilly's platform to connect with different third-party program administrators that help manage obesity treatment benefits and costs. ...

04.03.26 - 17:30	Here′s Why Eli Lilly (LLY) is a Strong Momentum Stock (Zacks)
	Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores....

03.03.26 - 21:36	Should You Forget Eli Lilly and Buy These Unstoppable Stocks Instead? (Fool)
	Lilly is leading the pack in the GLP-1 race, but this isn't a sprint, and you should consider more than just weight loss drugs....

03.03.26 - 12:01	Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Sanofi and Bayer (Zacks)
	LLY, JNJ, SNY and BAYRY ride strong pipelines and M&A momentum as Large-Cap Pharma rebounds in 2026 despite pricing and patent risks....

03.03.26 - 03:01	Eli Lilly stellt Markteinführungsstrategie für Adipositas-Medikament Orforglipron vor (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

02.03.26 - 19:00	LLY Wins CHMP Nod for Olumiant′s Expanded Use in Alopecia Areata (Zacks)
	Eli Lilly wins CHMP backing to expand Olumiant use in adolescents with severe alopecia areata, with the EU approval decision expected shortly....

02.03.26 - 18:36	Up Over 400% in 5 Years, Is It Too Late to Invest in Eli Lilly Stock? (Fool)
	Eli Lilly has been a growth beast in recent years, but its valuation has gotten fairly high along the way....

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Gemeinsame Beschäftigungen und Liebhabereien sind das Erste, worin sich eine wechselseitige Übereinstimmung hervortut. - Johann Wolfgang von Goethe

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram